About
Technology
Issues
FAQ
Links
Official Page
Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.